Our business unit Pharmaceuticals was able to significantly expand its cooperation with Blue Earth Therapeutics. We now also produce the therapeutic product Actinium (225Ac) rhPSMA for the British company. The radiopharmaceutical is used in Europe and the USA for clinical trials in the fight against prostate cancer.

More information >> Blue Earth press release